PAYS

NEUTRALEarnings

Paysign, Inc.

2026-08-21

Price

$14.09

+1.95%

This is the 2026-08-21 snapshot — the signals and analysis for PAYS as of this single trading day.

View full PAYS research hub →

Score4.8Watchlist

Signals5/8 DNA1/13 Act · 2/4 Risk

SentimentNEUTRALScore: 9

Volume1.6xvs 20d avg

Analysis

Paysign (PAYS) is undergoing high-conviction price discovery driven by a massive Q2 earnings beat, a 48% year-over-year revenue jump, and raised full-year guidance. Technical signals including SURGE and PERFECT_STACK, paired with 1.6x average volume, confirm urgent institutional accumulation that is easily absorbing recent insider selling and minor profit-taking. This aggressive buying is further emboldened by the current RISK_ON macro regime, where abundant Treasury liquidity and exceptionally tight credit spreads create a perfect tailwind for high-growth momentum leaders.

Fired Signals

SURGEALPHA MALEGOLDEN CROSSMARKET LEADERPERFECT STACKINSIDE OUTWEAK FINISHEXTENSION

Key Takeaways

Actionable Thesis: Go long PAYS to capitalize on its high-conviction breakout, fueled by pristine fundamentals, surging pharma/plasma revenues, and a wave of analyst price target hikes.
Key Risk: Extreme realized volatility (125.2% annualized) and potential buyer exhaustion following a +56.9% one-month run, highlighted by recent CFO profit-taking.
What to Watch: Monitor price action as it approaches the $15.00 Street-high price target, ensuring the $8.39 structural support holds during any broader market pullbacks.

← Back to 2026-08-21 View Full PAYS History →Yahoo Finance &nearr;